260 CHARLES STREET, WALTHAM, MA
Shareholders Approve Amendment to Equity Incentive Plan Increasing Shares
Departure of Chief Commercial Officer Theresa Greco Effective June 15, 2026
Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Annual Report to Security Holders
Appoints Mary Varghese Presti to Board of Directors
OptimizeRx Corporation Dismisses UHY LLP as Independent Accountant
Earnings Release
Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance
Q1
Q3
Q2
FY 2024
Notice of Late Filing for Quarterly Report
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Definitive Additional Information Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload